COMPARATIVE ANALYSIS OF TAMSULOSIN AND  TADALAFIL AS MEDICAL EXPULSIVE THERAPY FOR  URETERAL  STONES

M SEERWAN; I AHMAD; M ADNAN; H SHAFI; SAIFULLAH; M HUSSAIN

doi:10.54112/bcsrj.v2023i1.193

Authors

M SEERWAN Department of Urology, Gomal Medical College DI Khan, Pakistan
I AHMAD Department of Peads Urology, Bakhtawar Amin Medical & Dental College Multan, Pakistan
M ADNAN Department of Urology, Bakhtawar Amin Medical & Dental College Multan, Pakistan
H SHAFI Department of Urology, Sheikh Zayed Hospital Lahore, Pakistan
SAIFULLAH Department of Urology, Bakhtawar Amin Medical & Dental College Multan, Pakistan
M HUSSAIN Department of Urology, Sharif Medical & Dental College Lahore, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.193

Keywords:

Medical expulsive therapy, Tadalafil, Tamsulosin, Distal ureteral stones

Abstract

This study was designed to compare the efficacy of placebo, tamsulosin and tadalafil as expulsive medical therapy for removing distal ureteral stones. The prospective study was conducted in Multan, DI Khan & Lahore, from November 2021 to November 2022. The study included 129 subjects with distal ureteral stones sized ≤10mm. Subjects were randomly categorized into 3 groups, A, B and C, with 43 subjects each. Group A was administered tamsulosin 0.4 mg O.D., Group B was administered tadalafil 10 mg O.D. Subjects underwent therapy for 4 weeks. Duration and rate of stone expulsion, time and dose of NSAIDs, adverse effects and analgesic use of medication were recorded. The frequency of expulsion in groups A, B and C was 72.09%, 62.7% and 56.0%, respectively; this difference was statistically insignificant (p=.294). The mean expulsion time in groups A, B, and C was 17.65±1.2 days, 21.23±1.15 days and 22.35±1.16 days, respectively (p=.46). Frequency of endoscopic intervention after unsuccessful MET in groups A, B and C was 14 (32.5%), 18 (41.8%) and 20 (46.5%) respectively, the difference in frequency of endoscopic treatment among all groups was not significant (P=.294). Tamsulosin is a more effective MET for distal ureteral stones than tadalafil.

Downloads

Download data is not yet available.

References

De Coninck, V., Antonelli, J., Chew, B., Patterson, J. M., Skolarikos, A., and Bultitude, M. (2019). Medical expulsive therapy for urinary stones: future trends and knowledge gaps. European urology 76, 658-666.

Gnyawali, D., Pradhan, M. M., Sigdel, P. R., Parajuli, P., Chudal, S., Poudyal, S., Chapagain, S., Luitel, B. R., Chalise, P. R., and Sharma, U. (2020). Efficacy of Tamsulosin plus Tadalafil versus Tamsulosin as Medical Expulsive Therapy for Lower Ureteric Stones: A Randomized Controlled Trial. Advances in urology 2020.

Hsu, Y.-P., Hsu, C.-W., Bai, C.-H., Cheng, S.-W., Chen, K.-C., and Chen, C. (2018). Silodosin versus tamsulosin for medical expulsive treatment of ureteral stones: A systematic review and meta-analysis. PLoS One 13, e0203035.

Kava, B. R., Verbeek, A. E., Wruck, J. M., and Gittelman, M. (2019). Tamsulosin dispensation patterns in the United States: a real-world, longitudinal, population claims database analysis. Translational andrology and urology 8, 329.

Kızılay, F., Ülker, V., Çelik, O., Özdemir, T., Çakmak, Ö., Can, E., and Nazlı, O. (2019). The evaluation of the effectiveness of Gilaburu (Viburnum opulus L.) extract in the medical expulsive treatment of distal ureteral stones. Turkish Journal of Urology 45, S63.

Li, J. K., Qiu, S., Jin, K., Zheng, X. N., Tu, X., Bi, S. W., Liao, X. Y., Bao, Y. G., Yang, L., and Wei, Q. (2019). Efficacy and safety of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi of 5 to 10 mm in size: A systematic review and network meta‐analysis. The Kaohsiung Journal of Medical Sciences 35, 257-264.

Lim, I., Sellers, D. J., and Chess‐Williams, R. (2022). Current and emerging pharmacological targets for medical expulsive therapy. Basic & Clinical Pharmacology & Toxicology 130, 16-22.

Liu, H., Wang, S., Zhu, W., Lu, J., Wang, X., and Yang, W. (2020). Comparative efficacy of 22 drug interventions as medical expulsive therapy for ureteral stones: a systematic review and network meta-analysis. Urolithiasis 48, 447-457.

Marconi, M., Pavez, P., San Francisco, I., and Narvaez, P. (2019). Priapism induced by use of tamsulosin: a case report and review of the literature. Archivio Italiano di Urologia e Andrologia 91.

Ouyang, W., Sun, G., Long, G., Liu, M., Xu, H., Chen, Z., Ye, Z., Li, H., and Zhang, Y. (2020). Adjunctive medical expulsive therapy with tamsulosin for repeated extracorporeal shock wave lithotripsy: a systematic review and meta-analysis. International braz j urol 47, 23-35.

Parikh, C., Gurjar, V., and Shah, S. (2019). Tamsulosin versus tadalafil as medical expulsive therapy of distal ureteric stones: a comparative study. International Surgery Journal 6, 982-988.

Pricop, C., Șerban, D., Șerban, I., Cumpanas, A., and Puia, D. (2020). Does silodosin offer better results than tamsulosin as medical expulsive treatment after shock wave lithotripsy for single distal ureteric stones? Videosurgery and Other Miniinvasive Techniques 15, 602-607.

Schlomer, B. J. (2020). Urologic treatment of nephrolithiasis. Current opinion in pediatrics 32, 288-294.

Sebastianelli, A., Spatafora, P., Morselli, S., Vignozzi, L., Serni, S., McVary, K., Kaplan, S., Gravas, S., Chapple, C., and Gacci, M. (2020). Tadalafil alone or in combination with tamsulosin for the management for LUTS/BPH and ED. Current Urology Reports 21, 1-12.

Sun, X., Guan, W., Liu, H., Tang, K., Yan, L., Zhang, Y., Zeng, J., Chen, Z., Xu, H., and Ye, Z. (2018). Efficacy and safety of PDE5-Is and α-1 blockers for treating lower ureteric stones or LUTS: a meta-analysis of RCTs. BMC urology 18, 1-12.

Tzelves, L., Mourmouris, P., and Skolarikos, A. (2021). Comparison of current guidelines on medical management of stone disease. Archivos Espanoles de Urologia 74, 171-182.

Wang, Y., Chang, X., Li, J., and Han, Z. (2020). Efficacy and safety of various surgical treatments for proximal ureteral stone≥ 10mm: A systematic review and network meta-analysis. International braz j urol 46, 902-926.